Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene in Alzheimer's Disease
NCT00065767Phase 3Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2001
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raloxifene in Alzheimer's disease (AD), sponsored by University of Wisconsin–Madison. Started Sep 2001; status: completed.
02
Drugs
raloxifene
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00065767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065767.